Company Filing History:
Years Active: 2023
Title: **Innovative Drug Screening Platform by Yu-Ching Tung**
Introduction
Yu-Ching Tung is an accomplished inventor based in Taoyuan, Taiwan. With a focus on advancing medical technology, he has developed an innovative drug screening platform designed to simulate hyperthermic intraperitoneal chemotherapy. His work plays a critical role in enhancing cancer treatment methodologies.
Latest Patents
Yu-Ching Tung holds a patent for a drug screening platform that incorporates a dielectrophoresis system, a microfluidic chip, and a heating system. This platform effectively utilizes dielectrophoresis to generate forces that help arrange cells into a three-dimensional structure, thereby creating a tumor microenvironment. The system also features a drug mixing module that automates the preparation of various drug combinations, all while maintaining precise temperature control to mimic the conditions of hyperthermic chemotherapy.
Career Highlights
Yu-Ching Tung is affiliated with National Tsing Hua University, where he has contributed to significant advancements in the field of biomedical engineering. His innovative approach has positioned him at the forefront of research in cancer treatment technologies.
Collaborations
Throughout his career, Yu-Ching Tung has collaborated with notable colleagues, including Te-Yu Chao and Mao-Chih Hsieh. These collaborations have enabled him to enhance the capabilities of the drug screening platform and further its application in real-world settings.
Conclusion
With a keen focus on the intersection of technology and healthcare, Yu-Ching Tung continues to push the boundaries of innovation in cancer treatment. His patent for a drug screening platform is a testament to his dedication and ingenuity, promising to make a significant impact on the future of medical research and therapy.